Prior information guided deep-learning model for tumor bed segmentation in breast cancer radiotherapy.

BMC Med Imaging

Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.

Published: November 2024

AI Article Synopsis

  • Identifying the tumor bed (TB) after surgical removal of a tumor is essential for effective radiotherapy planning, but segmenting it from surrounding tissues using CT images poses significant challenges.
  • A new deep learning model enhances the delineation of TB by using prior tumor location information from both pre-operative and post-operative CT scans, improving accuracy in identifying treatment volumes.
  • The model demonstrated a significant improvement in segmenting TB, achieving a higher dice similarity coefficient compared to traditional methods and models without prior information, indicating better performance in clinical applications.

Article Abstract

Background And Purpose: Tumor bed (TB) is the residual cavity of resected tumor after surgery. Delineating TB from CT is crucial in generating clinical target volume for radiotherapy. Due to multiple surgical effects and low image contrast, segmenting TB from soft tissue is challenging. In clinical practice, titanium clips were used as marks to guide the searching of TB. However, this information is limited and may cause large error. To provide more prior location information, the tumor regions on both pre-operative and post-operative CTs are both used by the deep learning model in segmenting TB from surrounding tissues.

Materials And Methods: For breast cancer patient after surgery and going to be treated by radiotherapy, it is important to delineate the target volume for treatment planning. In clinical practice, the target volume is usually generated from TB by adding a certain margin. Therefore, it is crucial to identify TB from soft tissue. To facilitate this process, a deep learning model is developed to segment TB from CT with the guidance of prior tumor location. Initially, the tumor contour on the pre-operative CT is delineated by physician for surgical planning purpose. Then this contour is transformed to the post-operative CT via the deformable image registration between paired pre-operative and post-operative CTs. The original and transformed tumor regions are both used as inputs for predicting the possible region of TB by the deep-learning model.

Results: Compared to the one without prior tumor contour information, the dice similarity coefficient of the deep-learning model with the prior tumor contour information is improved significantly (0.812 vs. 0.520, P = 0.001). Compared to the traditional gray-level thresholding method, the dice similarity coefficient of the deep-learning model with the prior tumor contour information is improved significantly (0.812 vs.0.633, P = 0.0005).

Conclusions: The prior tumor contours on both pre-operative and post-operative CTs provide valuable information in searching for the precise location of TB on post-operative CT. The proposed method provided a feasible way to assist auto-segmentation of TB in treatment planning of radiotherapy after breast-conserving surgery.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571877PMC
http://dx.doi.org/10.1186/s12880-024-01469-0DOI Listing

Publication Analysis

Top Keywords

prior tumor
20
tumor contour
16
deep-learning model
12
target volume
12
pre-operative post-operative
12
post-operative cts
12
tumor
11
tumor bed
8
breast cancer
8
soft tissue
8

Similar Publications

Purpose: Carcinoembryonic antigen (CEA) is an important prognostic factor for rectal cancer. This study aims to introduce a novel cutoff point for CEA within the normal range to improve prognosis prediction and enhance patient stratification in rectal cancer patients.

Methods: A total of 316 patients with stages I to III rectal cancer who underwent surgical tumor resection were enrolled.

View Article and Find Full Text PDF

PMN-MDSCs are responsible for immune suppression in anti-PD-1 treated TAP1 defective melanoma.

Clin Transl Oncol

January 2025

Department of General Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, 510013, Guangdong, China.

Introduction: The transporter associated with antigen processing (TAP) is a key component of the classical HLA I antigen presentation pathway. Our previous studies have demonstrated that the downregulation of TAP1 contributes to tumor progression and is associated with an increased presence of myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment. However, it remains unclear whether the elevation of MDSCs leads to immune cell exhaustion in tumors lacking TAP1.

View Article and Find Full Text PDF

Purpose: Patients with partial or complete DPD deficiency have decreased capacity to degrade fluorouracil and are at risk of developing toxicity, which can be even life-threatening.

Case: A 43-year-old man with moderately differentiated rectal adenocarcinoma on capecitabine presented to the emergency department with complaints of nausea, vomiting, diarrhea, weakness, and lower abdominal pain for several days. Laboratory findings include grade 4 neutropenia (ANC 10) and thrombocytopenia (platelets 36,000).

View Article and Find Full Text PDF

Background: Autologous osteochondral transplantation (AOT) is an option to treat large osteochondral lesions of the talus (OLTs), accompanying subchondral cyst, and previous unsuccessful bone marrow stimulation (BMS) procedures. Although there is extensive literature on the outcomes of surgical interventions for medial osteochondral lesions, research focusing on lateral lesions remains limited. This article presents the intermediate-term clinical and radiologic outcomes following AOT for lateral OLTs.

View Article and Find Full Text PDF

Background: Esophageal squamous cell carcinoma (ESCC) is one of the most prevalent and lethal malignancies worldwide. Despite progress in immunotherapy for cancer treatment, its application and efficacy in ESCC remain limited. Therefore, there is an ongoing need to explore potential molecules and therapeutic strategies related to tumor immunity in ESCC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!